BR112013026114A2 - composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas - Google Patents

composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas

Info

Publication number
BR112013026114A2
BR112013026114A2 BR112013026114A BR112013026114A BR112013026114A2 BR 112013026114 A2 BR112013026114 A2 BR 112013026114A2 BR 112013026114 A BR112013026114 A BR 112013026114A BR 112013026114 A BR112013026114 A BR 112013026114A BR 112013026114 A2 BR112013026114 A2 BR 112013026114A2
Authority
BR
Brazil
Prior art keywords
nutritional compositions
branched chain
fatty acids
chain fatty
processes
Prior art date
Application number
BR112013026114A
Other languages
English (en)
Inventor
Doug Bolster
Jennifer Rae Mager
Norman Alan Greenberg
Zamzam Fariba Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112013026114A2 publication Critical patent/BR112013026114A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)

Abstract

resumo patente de invenção: "composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas". a presente invenção refere-se a composições nutricionais para melhorar, tratar e/ou evitar várias condições médicas e métodos de uso das mesmas. as condições médicas podem incluir alergias, doenças autoimunes, entre outras. as composições nutricionais incluem ácidos graxos de cadeia ramificada e podem incluir outros ingredientes funcionais tais como, porém não limitados a probióticos, nucleotídeos e aminoácidos. os métodos de administração de tais produtos nutricionais a indivíduos que necessitem também são fornecidos.
BR112013026114A 2011-04-12 2012-04-12 composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas BR112013026114A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161474452P 2011-04-12 2011-04-12
PCT/EP2012/056664 WO2012140133A1 (en) 2011-04-12 2012-04-12 Nutritional compositions including branched chain fatty acids and methods of using same

Publications (1)

Publication Number Publication Date
BR112013026114A2 true BR112013026114A2 (pt) 2016-12-27

Family

ID=45976923

Family Applications (3)

Application Number Title Priority Date Filing Date
BR112013026082A BR112013026082A2 (pt) 2011-04-12 2012-04-12 composições nutricionais incluindo ácidos graxos de cadeia ramificada para melhorar função de barreira intestinal
BR112013026114A BR112013026114A2 (pt) 2011-04-12 2012-04-12 composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas
BR112013026032A BR112013026032A2 (pt) 2011-04-12 2012-04-12 composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112013026082A BR112013026082A2 (pt) 2011-04-12 2012-04-12 composições nutricionais incluindo ácidos graxos de cadeia ramificada para melhorar função de barreira intestinal

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112013026032A BR112013026032A2 (pt) 2011-04-12 2012-04-12 composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida

Country Status (11)

Country Link
US (3) US20140037603A1 (pt)
EP (3) EP2696866A1 (pt)
JP (3) JP2014514304A (pt)
CN (3) CN103458890A (pt)
AU (3) AU2012241814A1 (pt)
BR (3) BR112013026082A2 (pt)
CA (3) CA2831679A1 (pt)
MX (3) MX2013011835A (pt)
SG (3) SG193928A1 (pt)
WO (3) WO2012140118A1 (pt)
ZA (2) ZA201308478B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
ITMI20130476A1 (it) 2013-03-28 2014-09-29 Novintethical Pharma Sagl Composizioni per il trattamento di disturbi gastro-intestinali a base di complessi di tannini con proteine
GB2516266A (en) * 2013-07-17 2015-01-21 Ziqian Jia A composition
CN103798596B (zh) * 2014-02-28 2015-04-22 青岛市中心医院 一种供心脑血管疾病患者食用的全营养配方食品
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
WO2015167002A1 (ja) * 2014-04-30 2015-11-05 味の素株式会社 消化管障害を改善する組成物
GB201417016D0 (en) * 2014-09-26 2014-11-12 Micromass Ltd Accurate mobility chromatograms
EP3616689A1 (en) * 2014-11-24 2020-03-04 Entrinsic Health Solutions, Inc. Amino acid compositions for the treatment of symptoms of disease
CN104544454A (zh) * 2014-12-19 2015-04-29 渤海大学 一种海参肽营养粉及其制备方法
WO2016116580A1 (en) * 2015-01-23 2016-07-28 Nestec S.A. Nutritional composition useful in the treatment of ibd patients
US20160324904A1 (en) * 2015-05-05 2016-11-10 Ryozo Saito Supplement for improving immunotolerance, intestinal environment and intestinal tract barrier
US20180071237A1 (en) * 2015-05-05 2018-03-15 Ryozo Saito Treatment method for improving intestinal enviornment and intestinal tract barrier
US11234949B2 (en) * 2015-05-14 2022-02-01 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
JP6964960B2 (ja) * 2015-11-13 2021-11-10 ニュートリー株式会社 術後の創傷部及び／又は吻合部の回復を促進するための栄養組成物
CN108348483A (zh) * 2015-12-04 2018-07-31 雀巢产品技术援助有限公司 用于治疗或预防与组织中的超过正常数量的粒细胞相关联的疾病的可可多酚和可溶膳食纤维
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN105901703B (zh) * 2016-04-19 2020-03-10 上海海洋大学 一种用于烧伤患者的海洋生物型肠内营养制剂
CN106036655A (zh) * 2016-06-21 2016-10-26 宋庆利 一种主食制品及其用途以及含其的含乳饮料的制备方法
CN106213522A (zh) * 2016-08-05 2016-12-14 郑家福 营养保健品
RU2019110875A (ru) 2016-09-13 2020-10-15 Аллерган, Инк. Небелковые композиции клостридиального токсина
JP2018052890A (ja) * 2016-09-30 2018-04-05 ニュートリー株式会社 術後の創傷治癒過程における炎症期の創傷治癒を促進するための栄養組成物
AU2017376591A1 (en) * 2016-12-15 2019-04-18 Société des Produits Nestlé S.A. Composition in powder form comprising iron-casein complexes and compounds sensitive to oxidation
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN107519197A (zh) * 2017-01-13 2017-12-29 江苏西宏生物医药有限公司 一种果胶组合物
JP2018172329A (ja) * 2017-03-31 2018-11-08 公立大学法人岩手県立大学 肉芽形成促進組成物
US9795579B1 (en) * 2017-04-24 2017-10-24 Knoze Jr. Corporation Oral microbiota promoting method
EP3641566A1 (en) 2017-06-21 2020-04-29 Abbott Laboratories Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
KR102406166B1 (ko) * 2017-08-25 2022-06-10 강릉원주대학교산학협력단 아무르불가사리 지방산을 유효성분으로 포함하는 면역 증강용 조성물
CN107982513A (zh) * 2017-11-29 2018-05-04 北京艾沃森科技有限公司 一种盐藻地龙蛋白复方保健品及其制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
RU2677861C1 (ru) * 2018-05-11 2019-01-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство на основе березовых термированных опилок для лечения кожно-мышечных ран у сельскохозяйственных животных
CN108782764B (zh) * 2018-05-18 2022-01-11 石家庄君乐宝乳业有限公司 预防结肠炎的婴幼儿奶粉及其制备方法
US20210308196A1 (en) * 2018-06-01 2021-10-07 Evolve Biosystems, Inc. Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP2021535086A (ja) * 2018-08-29 2021-12-16 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 腸の健康を改善するための製剤
WO2020132296A1 (en) * 2018-12-20 2020-06-25 Pantheryx, Inc. Medical nutrition product composition for acute diarrhea
WO2021046464A1 (en) * 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of nutritional supplementation affecting microbiome metabolism
CN110742266B (zh) * 2019-11-11 2022-11-01 江南大学 一种辅助调节肠道免疫功能的全营养配方食品
CN111000042A (zh) * 2019-12-31 2020-04-14 福建天马科技集团股份有限公司 一种加州鲈鱼淡水养殖专用饲料，及其投喂用设备
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用
CN113637603B (zh) * 2021-07-12 2023-07-25 南京大学 一种肠道乳杆菌及其应用
WO2023031226A1 (en) * 2021-08-31 2023-03-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of branched chain fatty acids (bcfas) for the treatment of intestinal inflammation
CN115606691B (zh) * 2022-12-19 2023-07-11 中国农业科学院北京畜牧兽医研究所 生物素作为奶牛饲料添加剂中的用途
CN115969957B (zh) * 2022-12-21 2023-07-11 浙江佰穗莱生命健康科技有限公司 一种炎性肠病复合益生菌制剂及其制备方法
CN116121154B (zh) * 2023-04-10 2023-06-27 四川厌氧生物科技有限责任公司 一种乳明串珠菌及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56154414A (en) * 1980-04-30 1981-11-30 Tsuruhara Seiyaku Kk Antiulcerative containing fatty acid or its derivative
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
US5866418A (en) 1990-07-13 1999-02-02 Gropep Pty. Ltd. Milk protein mixture for promoting growth of animal cells or treating wounds and method of making and methods employing the mixture
FR2705234B1 (fr) * 1993-05-19 1995-08-04 Geffard Michel Utilisation de molécules reconnues par des autoanticorps de sérums humains pour le diagnostic ou le traitement du SIDA.
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
US6333041B1 (en) * 1998-03-02 2001-12-25 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
CN1108796C (zh) * 1998-10-16 2003-05-21 杨振华 一种抗癌物质的应用及其生产方法
CA2444470A1 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
AU2002322828A1 (en) 2001-08-03 2003-02-24 Zhenhua Yang A group of novel anti-cancer compounds with specific structure
US8394370B2 (en) * 2003-06-23 2013-03-12 Nestec S.A. Nutritional formula for optimal gut barrier function
EP1723951A1 (en) * 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
US8636982B2 (en) * 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009039101A1 (en) * 2007-09-17 2009-03-26 Cornell University Branched chain fatty acids for prevention or treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
MX2013011835A (es) 2013-11-01
CN103458888A (zh) 2013-12-18
US20140037603A1 (en) 2014-02-06
CN103458889A (zh) 2013-12-18
CA2830970A1 (en) 2012-10-18
MX2013011834A (es) 2014-02-11
AU2012241814A1 (en) 2013-10-03
JP2014511871A (ja) 2014-05-19
CN103458890A (zh) 2013-12-18
WO2012140132A1 (en) 2012-10-18
EP2696868A1 (en) 2014-02-19
AU2012241895A1 (en) 2013-10-03
US20140037602A1 (en) 2014-02-06
AU2012241815A1 (en) 2013-09-26
JP2014514304A (ja) 2014-06-19
EP2696866A1 (en) 2014-02-19
JP2014510775A (ja) 2014-05-01
ZA201308478B (en) 2015-08-26
SG193927A1 (en) 2013-11-29
CA2831341A1 (en) 2012-10-18
SG193926A1 (en) 2013-11-29
SG193928A1 (en) 2013-11-29
EP2696867A1 (en) 2014-02-19
US20140037601A1 (en) 2014-02-06
ZA201308469B (en) 2015-08-26
BR112013026082A2 (pt) 2019-09-24
MX2013011836A (es) 2014-02-11
BR112013026032A2 (pt) 2016-12-20
WO2012140133A1 (en) 2012-10-18
WO2012140118A1 (en) 2012-10-18
CA2831679A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
BR112013026114A2 (pt) composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas
BR112014008511A2 (pt) composições nutricionais com fitonutrientes
CR11817A (es) Anticuerpos anti-factor d humanizados y sus usos
BR112013026706A2 (pt) composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico
AR063760A1 (es) Anticuerpos anti-factor d humanizados y usos de los mismos
EP2528934A4 (en) AROMATIC-CATIONIC PEPTIDES AND USES THEREOF
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
BR112015014372A8 (pt) inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas".
BR112014009526B8 (pt) Composição de vacina compreendendo pd-l1, kit de partes compreendendo tal composição e uso dos mesmos para tratar ou prevenir câncer
BR112014016557A8 (pt) métodos de tratamento de sintomas comportamentais de distúrbios neurológicos e mentais
WO2013142124A8 (en) Solid forms of a thiophosphoramidate nucleotide prodrug
BR112019024747A2 (pt) formulações de dose fixa
BR112012001912A8 (pt) Composições nutritivas que compreendem fibra e probióticos
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
CL2021000207A1 (es) Nuevas proteínas de fusión específicas para cd137 y pd-l1
BR112012016853A2 (pt) "composições farmacêuticas para administração oral de peptídeos de insulina".
BR112013025047A2 (pt) composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
BR112015013349A2 (pt) trieptanoína para o tratamento de deficiência de transportador de glicose 1
BR112014001665A2 (pt) compostos de 2,3-di-hidroimidazo[1,2-c]pirimidin-5(1h)-ona utilizados como inibidores de lp-plaz
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
MX2018000447A (es) Novedosas proteinas especificas para lag-3.
WO2018068947A3 (de) Proteinhydrolysate
NZ705917A (en) Nootropic compositions for improving memory performance
BR112015030431A2 (pt) formulação de liberação modificada

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]